Navigation Links
Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
Date:2/3/2009

SAN DIEGO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE: CXM) today reported on recent clinical findings published in The New England Journal of Medicine showing the long-term outcome of a method of gene therapy to treat infant children with a fatal disorder of the immune system. The infant children studied had a rare form of severe combined immunodeficiency (SCID). SCID arises in infants with a genetic defect that leaves them unable to produce an enzyme called adenosine deaminase. This key enzyme is most active in lymphocytes, which are white blood cells vitally important for protection against infection by bacteria, viruses and fungi. Infants who inherit this fatal genetic abnormality develop impaired immune responses, leading to recurrent infections and a failure to thrive. Without adequate treatment, these children typically die within one year of birth.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The New England Journal of Medicine (NEJM) reported on the success of a DNA-based approach for the introduction of a normal adenosine deaminase gene into the patient's hematopoietic stem cells that have been removed from the bone marrow. After transfection of the cells with the gene, the cells are re-infused back into the patients after nonmyeloablative conditioning with busulfan. After a single treatment, all 10 children in the study survived and gene therapy was not associated with any adverse events during a median follow-up of 4 years. In 8 of the 10 patients, there was excellent and persistent immune reconstitution and protection from infection.

In an accompanying NEJM editorial entitled, Gene Therapy Fulfilling Its Promise, the authors noted, "The prospects of cont
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
5. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
6. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
7. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Stem Cell Therapy to Skyrocket by 2017
10. Team demos safety of RNA therapy
11. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 Research presented at the 2015 ... on the studies that led to a fingerprick Ebola ... this disease to receive approval from the World Health ... Ebola,s grip on West Africa ... healthcare workers to isolate and treat these patients much ...
(Date:7/27/2015)... NEW YORK , July 27, 2015 /PRNewswire-USNewswire/ ... today announced the winners of its annual ... basic research by scientists who have been supported ... early career scientists to pursue innovative ideas in ... generate "proof" of concept for the early detection, ...
(Date:7/27/2015)... Princeton Junction, NJ (PRWEB) , ... July 27, 2015 , ... ... Awards, which identify and celebrate the top 100 most innovative technologies and services of ... ® which was named in the Software/Services category. The winners will be announced at ...
(Date:7/24/2015)... Ryan & Maniskas, LLP that a class action ... the Northern District of California on ... stock of Avalanche Biotechnologies, Inc. ("Avalanche" or the "Company") (NASDAQ: ... 2015, inclusive (the "Class Period"). Avalanche shareholders may, ... appointment as a lead plaintiff of the Class.  If you ...
Breaking Biology Technology:Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3
... Mass. Cat fanciers everywhere appreciate the gravity-defying grace and ... those traits extend even to the way cats lap milk? ... the way domestic and big cats lap and found that ... between two physical forces. The results will be published ...
... heart implanted micro robot operate permanently? Can cell phones and ... their batteries charged? It might sound like science fiction, ... future. The team of Prof. Keon Jae ... Zhong Lin Wang (Georgia Institute of Technology, Dept. of Materials ...
... City, November 11, 2010 Professor Federico Rosei of ... as the recipient of the prestigious 2010 Friedrich Wilhelm ... Foundation. The foundation grants 25 of these awards annually ... Rosei was selected in recognition of the caliber and ...
Cached Biology Technology:Cats show perfect balance even in their lapping 2Cats show perfect balance even in their lapping 3Cats show perfect balance even in their lapping 4New forms of highly efficient, flexible nanogenerator technology 2INRS professor Federico Rosei receives a 2010 Friedrich Wilhelm Bessel Research Award 2
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... Li et al. explain how prolonged stress sparks the ... cells to undergo apoptosis in several aging-related diseases.The study ... the Journal of Cell Biology (online September ... in the ER. Cells try to recover by slowing ...
... understanding of how anesthesia and anesthesia-like states are controlled ... future treatments of various states of loss of consciousness, ... Jerusalem scientists. In an article published in ... Devor, the Cecile and Seymour Alpert Professor of Pain ...
... The same properties of nanoparticles that make them so ... the environment and human health. However, little is ... problem is determining exactly what a nanoparticle is. ... from the Center for the Environmental Implications of NanoTechnology ...
Cached Biology News:'Alert status' area in brain discoved by Hebrew University scientists 2When nano may not be nano 2When nano may not be nano 3
MHC II (HLA-DP)...
... is a new product number, created to ... no availability yet, please order under the ... service for assistance. ID clarifier: ... H 100 20 mm surface ...
BD BioCoat Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... 5-OxoETE-d7 is used as an internal ... stable isotope dilution mass spectrometry. 5-OxoETE is ... oxidation of 5-HETE in human neutrophils. It ... an EC50 of 2 nM. 5-OxoETE selectively ...
Biology Products: